drugs
|
specialties
|
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Malaysia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Download App
Malaysia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Vessel Due F
Vessel Due F
sulodexide
Manufacturer:
AlfaSigma
Distributor:
Zuellig Pharma
Marketer:
EP Plus Group
Concise Prescribing Info
Contents
Sulodexide
Indications/Uses
Vascular pathologies w/ thrombotic risk.
Dosage/Direction for Use
1 amp daily IM or IV for 15-20 days then, continue treatment w/ 1 cap bd for 30-40 days. Repeat treatment cycle at least twice yrly.
Administration
Should be taken on an empty stomach.
Contraindications
Hypersensitivity to heparin or heparin-like products. Diathesis & haemorrhagic diseases. Pregnancy.
Special Precautions
Monitor haemocoagulative parameters periodically.
Adverse Reactions
Nausea, vomiting, epigastralgia. Pain, burning sensation & haematoma at inj site.
View
ADR Monitoring Form
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AB11 - sulodexide ; Belongs to the class of heparin group. Used in the treatment of thrombosis.
Regulatory Classification
B
Presentation/Packing
Form
Vessel Due F cap 250 LSU
Packing/Price
50's
Form
Vessel Due F inj 600 LSU
Packing/Price
10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in